Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
30646 | 165 | 45.8 | 88% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
602 | 3 | OSTEOPONTIN//AMELOGENIN//TOOTH DEVELOPMENT | 14479 |
3126 | 2 | PERIOSTIN//CONNECTIVE TISSUE GROWTH FACTOR//CTGF | 2280 |
30646 | 1 | OSTEOACTIVIN//GPNMB//GLYCOPROTEIN NON METASTATIC MELANOMA PROTEIN B | 165 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | OSTEOACTIVIN | authKW | 2904687 | 12% | 83% | 19 |
2 | GPNMB | authKW | 2059829 | 10% | 70% | 16 |
3 | GLYCOPROTEIN NON METASTATIC MELANOMA PROTEIN B | authKW | 1133513 | 4% | 88% | 7 |
4 | REPETITIVE MOTION INJURY | authKW | 605657 | 4% | 55% | 6 |
5 | GLYCOPROTEIN NMB | authKW | 555191 | 2% | 100% | 3 |
6 | DC HIL | authKW | 416392 | 2% | 75% | 3 |
7 | CDX 011 | authKW | 370127 | 1% | 100% | 2 |
8 | CR011 VCMMAE | authKW | 370127 | 1% | 100% | 2 |
9 | GLYCOPROTEIN NONMETASTATIC MELANOMA B | authKW | 370127 | 1% | 100% | 2 |
10 | HGFIN | authKW | 370127 | 1% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 257 | 22% | 0% | 36 |
2 | Cell Biology | 219 | 20% | 0% | 33 |
3 | Orthopedics | 103 | 7% | 0% | 12 |
4 | Physiology | 94 | 9% | 0% | 15 |
5 | Medicine, Research & Experimental | 77 | 9% | 0% | 15 |
6 | Sport Sciences | 76 | 5% | 0% | 9 |
7 | Neurosciences | 66 | 14% | 0% | 23 |
8 | Biochemistry & Molecular Biology | 35 | 16% | 0% | 27 |
9 | Immunology | 32 | 8% | 0% | 14 |
10 | Rheumatology | 23 | 2% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TEMPLE MED | 328998 | 2% | 44% | 4 |
2 | ENGN MANAGEMENT SERV | 185064 | 1% | 100% | 1 |
3 | HLTH RELATED PROFESS RUTGERS | 185064 | 1% | 100% | 1 |
4 | LEUKEMIA LYMPHOMA PROGRAMLEUKEMIA PROGRAM | 185064 | 1% | 100% | 1 |
5 | MOL HISTOL CORE IL | 185064 | 1% | 100% | 1 |
6 | PHYS THER Y ANAT CELL BIOL | 185064 | 1% | 100% | 1 |
7 | THEORET PL SCI TAS | 185064 | 1% | 100% | 1 |
8 | MOL ENZYME CHEM | 92531 | 1% | 50% | 1 |
9 | TRI SERV ORTHODONT IDENCY PROGRAM | 92531 | 1% | 50% | 1 |
10 | ONCOL HEMATOL IMMUNOL RHEUMATOL PULMOL | 92529 | 1% | 25% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION | 3479 | 2% | 1% | 3 |
2 | EXERCISE AND SPORT SCIENCES REVIEWS | 1652 | 1% | 0% | 2 |
3 | THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | 1283 | 1% | 1% | 1 |
4 | BMC MUSCULOSKELETAL DISORDERS | 951 | 2% | 0% | 4 |
5 | JOURNAL OF CELL COMMUNICATION AND SIGNALING | 782 | 1% | 0% | 1 |
6 | JOURNAL OF CELLULAR BIOCHEMISTRY | 740 | 4% | 0% | 6 |
7 | JOURNAL OF CELLULAR PHYSIOLOGY | 655 | 4% | 0% | 6 |
8 | JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS | 593 | 1% | 0% | 1 |
9 | CELL COMMUNICATION AND SIGNALING | 490 | 1% | 0% | 1 |
10 | GENES AND NUTRITION | 384 | 1% | 0% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | OSTEOACTIVIN | 2904687 | 12% | 83% | 19 | Search OSTEOACTIVIN | Search OSTEOACTIVIN |
2 | GPNMB | 2059829 | 10% | 70% | 16 | Search GPNMB | Search GPNMB |
3 | GLYCOPROTEIN NON METASTATIC MELANOMA PROTEIN B | 1133513 | 4% | 88% | 7 | Search GLYCOPROTEIN+NON+METASTATIC+MELANOMA+PROTEIN+B | Search GLYCOPROTEIN+NON+METASTATIC+MELANOMA+PROTEIN+B |
4 | REPETITIVE MOTION INJURY | 605657 | 4% | 55% | 6 | Search REPETITIVE+MOTION+INJURY | Search REPETITIVE+MOTION+INJURY |
5 | GLYCOPROTEIN NMB | 555191 | 2% | 100% | 3 | Search GLYCOPROTEIN+NMB | Search GLYCOPROTEIN+NMB |
6 | DC HIL | 416392 | 2% | 75% | 3 | Search DC+HIL | Search DC+HIL |
7 | CDX 011 | 370127 | 1% | 100% | 2 | Search CDX+011 | Search CDX+011 |
8 | CR011 VCMMAE | 370127 | 1% | 100% | 2 | Search CR011+VCMMAE | Search CR011+VCMMAE |
9 | GLYCOPROTEIN NONMETASTATIC MELANOMA B | 370127 | 1% | 100% | 2 | Search GLYCOPROTEIN+NONMETASTATIC+MELANOMA+B | Search GLYCOPROTEIN+NONMETASTATIC+MELANOMA+B |
10 | HGFIN | 370127 | 1% | 100% | 2 | Search HGFIN | Search HGFIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ZHUO, H , ZHOU, LT , (2016) GPNMB/OSTEOACTIVIN: AN INDICATOR AND THERAPEUTIC TARGET IN TUMOR AND NON-TUMOROUS LESIONS.PHARMAZIE. VOL. 71. ISSUE 10. P. 555 -561 | 56 | 69% | 0 |
2 | ZHOU, LT , LIU, FY , LI, Y , PENG, YM , LIU, YH , LI, J , (2012) GPNMB/OSTEOACTIVIN, AN ATTRACTIVE TARGET IN CANCER IMMUNOTHERAPY.NEOPLASMA. VOL. 59. ISSUE 1. P. 1-5 | 35 | 90% | 16 |
3 | MARIC, G , ROSE, AAN , ANNIS, MG , SIEGEL, PM , (2013) GLYCOPROTEIN NON-METASTATIC B (GPNMB): A METASTATIC MEDIATOR AND EMERGING THERAPEUTIC TARGET IN CANCER.ONCOTARGETS AND THERAPY. VOL. 6. ISSUE . P. 839 -852 | 49 | 49% | 22 |
4 | HUANG, JJ , MA, WJ , YOKOYAMA, S , (2012) EXPRESSION AND IMMUNOLOCALIZATION OF GPNMB, A GLIOMA-ASSOCIATED GLYCOPROTEIN, IN NORMAL AND INFLAMED CENTRAL NERVOUS SYSTEMS OF ADULT RATS.BRAIN AND BEHAVIOR. VOL. 2. ISSUE 2. P. 85-96 | 30 | 64% | 15 |
5 | SINGH, M , DEL CARPIO-CANO, F , BELCHER, JY , CRAWFORD, K , FRARA, N , OWEN, TA , POPOFF, SN , SAFADI, FF , (2010) FUNCTIONAL ROLES OF OSTEOACTIVIN IN NORMAL AND DISEASE PROCESSES.CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION. VOL. 20. ISSUE 4. P. 341 -357 | 39 | 51% | 12 |
6 | HUANG, YY , BAI, B , YAO, YC , (2016) PROSPECTS OF OSTEOACTIVIN IN TISSUE REGENERATION.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 20. ISSUE 11. P. 1357 -1364 | 33 | 46% | 0 |
7 | OTT, PA , HAMID, O , PAVLICK, AC , KLUGER, H , KIM, KB , BOASBERG, PD , SIMANTOV, R , CROWLEY, E , GREEN, JA , HAWTHORNE, T , ET AL (2014) PHASE I/II STUDY OF THE ANTIBODY-DRUG CONJUGATE GLEMBATUMUMAB VEDOTIN IN PATIENTS WITH ADVANCED MELANOMA.JOURNAL OF CLINICAL ONCOLOGY. VOL. 32. ISSUE 32. P. 3659 -+ | 23 | 55% | 16 |
8 | ROSE, AAN , ANNIS, MG , DONG, ZF , PEPIN, F , HALLETT, M , PARK, M , SIEGEL, PM , (2010) ADAM10 RELEASES A SOLUBLE FORM OF THE GPNMB/OSTEOACTIVIN EXTRACELLULAR DOMAIN WITH ANGIOGENIC PROPERTIES.PLOS ONE. VOL. 5. ISSUE 8. P. - | 22 | 59% | 49 |
9 | ABDELMAGID, SM , BARBE, MF , SAFADI, FF , (2015) ROLE OF INFLAMMATION IN THE AGING BONES.LIFE SCIENCES. VOL. 123. ISSUE . P. 25 -34 | 44 | 26% | 9 |
10 | SHENG, MHC , WERGEDAL, JE , MOHAN, S , AMOUI, M , BAYLINK, DJ , LAU, KHW , (2012) TARGETED OVEREXPRESSION OF OSTEOACTIVIN IN CELLS OF OSTEOCLASTIC LINEAGE PROMOTES OSTEOCLASTIC RESORPTION AND BONE LOSS IN MICE.PLOS ONE. VOL. 7. ISSUE 4. P. - | 21 | 62% | 11 |
Classes with closest relation at Level 1 |